Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tranchant, C.
Right arrow Articles by Warter, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tranchant, C.
Right arrow Articles by Warter, J. M.
Neurology 1999;52:1244
© 1999 American Academy of Neurology
Articles

Basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease

C. Tranchant, MD, L. Geranton, PharmD, C. Guiraud–Chaumeil, MD, M. Mohr, MD and J. M. Warter, MD

From the Service des Maladies du Système Nerveux et du Muscle (Drs. Tranchant, Guiraud–Chaumeil, and Warter, and L. Geranton), Hôpitaux Universitaires; and the Institut de Pathologie (Dr. Mohr), Faculté de Médecine, Strasbourg, France.

Address correspondence and reprint requests to Dr. C. Tranchant, Service des Maladies du Système Nerveux et du Muscle, Hôpitaux Universitaires 1, Place de l’Hôpital, BP 426, 67091 Strasbourg, France.

OBJECTIVE: To determine the correlation of clinical and pathologic features with prion protein (PrP) gene polymorphism at codon 129 and with biochemical characteristics of the protease-resistant PrP (PrPres) in sporadic Creutzfeldt–Jakob disease (CJD).

METHODS: Clinical data acquisition, determination of the codon 129 genotype of the PrP gene, brain pathologic study, and immunoblot analysis of crude brain extracts were carried out in 14 patients.

RESULTS: The first group of 10 subjects showed the classic clinical triad, with dementia, myoclonus, and periodic sharp waves on EEG. None of the subjects had amyloid plaques, but PrP immunoreactivity was of diffuse synaptic type in the cerebellar cortex. All subjects were methionine–methionine at codon 129 and the PrPres had a biochemical profile of type 1 (unglycosylated band of 21.5 kD). A second group of three patients showed cerebellar ataxia and later dementia. Periodic sharp waves on EEG were absent. PrP amyloid plaques predominated in the cerebellar cortex, along with diffuse PrP immunoreactivity. These subjects were valine–valine at codon 129 and had a type 2 PrPres (unglycosylated band of 19.4 kD). In the last patient cerebellar ataxia and dementia appeared simultaneously. Many Kuru-type plaques were present in the cerebellar cortex; many PrP amyloid plaques were present in the basal ganglia. This patient was methionine-valine at codon 129 and the PrPres was of type 1.

CONCLUSIONS: The codon 129 genotype is only one of the factors determining CJD phenotype, and the biochemical pattern of PrP has no direct correlation with this phenotype.




This article has been cited by other articles:


Home page
 NeurologyHome page
R. Y.-Y. Lo, W. C. Shyu, and H. Li
Long-duration sCJD with PRNP codon 129 methionine homozygosity and cerebral cortical plaques
Neurology, June 27, 2006; 66(12): 1944 - 1945.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. S. Knopman, S. T. DeKosky, J. L. Cummings, H. Chui, J. Corey-Bloom, N. Relkin, G. W. Small, B. Miller, and J. C. Stevens
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 8, 2001; 56(9): 1143 - 1153.
[Abstract] [Full Text] [PDF]